title: Effects of 1,25-dihydroxicolecalciferol and dietary calcium-phosphate on distribution of lead to tissues during growth.
abstract: The susceptibility to the toxic effects of lead (Pb) is mainly mediated by age and nutritional and hormonal status, and children are among the most vulnerable to them. During growth, an increase in calcium, phosphate and vitamin D in diet is recommended to enhance calcium and phosphate intestinal absorption and bone deposit. Calcium and phosphate reduce lead intestinal absorption, and 1,25-dihydroxicolecalciferol (1,25(OH)2D3) (active metabolite of vitamin D) increases both lead and calcium intestinal absorption. However, the effects of 1,25(OH)2D3 on lead bone deposit and redistribution to soft tissues are not well known. In this study, we examined the effects of calcium-phosphate diet supplementation and the administration of 1,25(OH)2D3 on Pb distribution to soft tissue and bone in growing rats exposed to Pb. Rats (21 days old) were exposed for 28 days to 100 ppm of Pb solution in drinking water. Calcium and phosphate in diet were increased from 1 to 2.5% and from 0.65 to 1.8%, respectively, and 1,25(OH)2D3 was administrated by intraperitoneal injection of 7.2 ng/kg every 7 days. Between 21 and 49 days, the body weight increased about 5 times. The results showed that high calcium-phosphate diet led to lower Pb concentration in blood and in bone, but Pb liver and kidney concentrations increased, which indicates that absorption and bone deposit redistribution of Pb decreased. On the other hand, no effect of this diet rich in calcium-phosphate in Pb concentration was observed in brain. Blood and bone Pb concentrations increased even more when the high calcium-phosphate diet included 1,25(OH)2D3. In the rats treated only with 1,25(OH)2D3, blood and bone Pb concentrations were lower. Higher concentrations of lead in the soft organs were observed also in rats treated under a high calcium-phosphate diet plus 1,25(OH)2D3 administration. The above mentioned results suggested that 1,25(OH)2D3 induces an increased absorption and redistribution of Pb, and therefore, it may enhance systemic damage in Pb-exposed growing animals.
authors.affiliation: Department of Biochemistry, Centro de Investigación y de Estudios Avanzados del IPN, PO Box 14-740, México City 07000, México.
authors.forename: G E
authors.initials: GE
authors.lastname: Cortina-Ramírez
authors.forename: J
authors.initials: J
authors.lastname: Cerbón-Solorzano
authors.forename: J V
authors.initials: JV
authors.lastname: Calderón-Salinas
mesh_terms: D000375:Aging / Q000378:metabolism*; D000818:Animals; D002117:Calcitriol / Q000008:administration & dosage / Q000494:pharmacology*; D002136:Calcium, Dietary / Q000008:administration & dosage / Q000494:pharmacology*; D007274:Injections, Intraperitoneal; D007854:Lead / Q000097:blood / Q000493:pharmacokinetics*; D008297:Male; D016226:Phosphorus, Dietary / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D014018:Tissue Distribution; D014815:Vitamins / Q000008:administration & dosage / Q000494:pharmacology
chemical_list: D002136:Calcium, Dietary; D016226:Phosphorus, Dietary; D014815:Vitamins; D007854:Lead; D002117:Calcitriol